Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.

Saved in:
Bibliographic Details
Title: Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.
Authors: Diamond B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Chahar D; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida., Jain MD; Lymphoma Service, Moffitt Cancer Center, Tampa, Florida., Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany., Durante MA; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Ziccheddu B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Kaddoura M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Papadimitriou M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Maclachlan KH; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Jelinek T; Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Davies FE; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Figura NB; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida., Morgan GJ; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Mai EK; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Weisel K; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Usmani S; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Locke FL; Lymphoma Service, Moffitt Cancer Center, Tampa, Florida., Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Schatz JH; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida., Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Maura F; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Source: Blood cancer discovery [Blood Cancer Discov] 2025 Sep 03; Vol. 6 (5), pp. 450-463.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40402512
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Diamond+B%22">Diamond B</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Chahar+D%22">Chahar D</searchLink>; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Jain+MD%22">Jain MD</searchLink>; Lymphoma Service, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Poos+AM%22">Poos AM</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Durante+MA%22">Durante MA</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Ziccheddu+B%22">Ziccheddu B</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Kaddoura+M%22">Kaddoura M</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Papadimitriou+M%22">Papadimitriou M</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Maclachlan+KH%22">Maclachlan KH</searchLink>; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Jelinek+T%22">Jelinek T</searchLink>; Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Davies+FE%22">Davies FE</searchLink>; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Figura+NB%22">Figura NB</searchLink>; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Morgan+GJ%22">Morgan GJ</searchLink>; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Mai+EK%22">Mai EK</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weisel+K%22">Weisel K</searchLink>; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Fenk+R%22">Fenk R</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Usmani+S%22">Usmani S</searchLink>; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Landgren+O%22">Landgren O</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Locke+FL%22">Locke FL</searchLink>; Lymphoma Service, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schatz+JH%22">Schatz JH</searchLink>; Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Weinhold+N%22">Weinhold N</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Maura+F%22">Maura F</searchLink>; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101764786%22">Blood cancer discovery</searchLink> [Blood Cancer Discov] 2025 Sep 03; Vol. 6 (5), pp. 450-463.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101764786 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2643-3249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226433230%22">26433230 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40402512
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2643-3230.BCD-24-0328
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 450
    Titles:
      – TitleFull: Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Diamond B
      – PersonEntity:
          Name:
            NameFull: Chahar D
      – PersonEntity:
          Name:
            NameFull: Jain MD
      – PersonEntity:
          Name:
            NameFull: Poos AM
      – PersonEntity:
          Name:
            NameFull: Durante MA
      – PersonEntity:
          Name:
            NameFull: Ziccheddu B
      – PersonEntity:
          Name:
            NameFull: Kaddoura M
      – PersonEntity:
          Name:
            NameFull: Papadimitriou M
      – PersonEntity:
          Name:
            NameFull: Maclachlan KH
      – PersonEntity:
          Name:
            NameFull: Jelinek T
      – PersonEntity:
          Name:
            NameFull: Davies FE
      – PersonEntity:
          Name:
            NameFull: Figura NB
      – PersonEntity:
          Name:
            NameFull: Morgan GJ
      – PersonEntity:
          Name:
            NameFull: Mai EK
      – PersonEntity:
          Name:
            NameFull: Weisel K
      – PersonEntity:
          Name:
            NameFull: Fenk R
      – PersonEntity:
          Name:
            NameFull: Raab MS
      – PersonEntity:
          Name:
            NameFull: Usmani S
      – PersonEntity:
          Name:
            NameFull: Landgren O
      – PersonEntity:
          Name:
            NameFull: Locke FL
      – PersonEntity:
          Name:
            NameFull: Goldschmidt H
      – PersonEntity:
          Name:
            NameFull: Schatz JH
      – PersonEntity:
          Name:
            NameFull: Weinhold N
      – PersonEntity:
          Name:
            NameFull: Maura F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 09
              Text: 2025 Sep 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2643-3249
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Blood cancer discovery
              Type: main
ResultId 1